Lucid Diagnostics closes $28.8 million stock offering Sep 11, 2025 09:18AM
Lucid Diagnostics Announces Closing of Public Offering of Common Stock Sep 11, 2025 09:17AM
Lucid Diagnostics prices 25 million share offering at $1.00 per share Sep 10, 2025 08:01AM
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock Sep 10, 2025 08:00AM
Lucid Diagnostics announces proposed public stock offering Sep 9, 2025 04:01PM


Sep 9, 2025 04:01PM Lucid Diagnostics announces proposed public stock offering
Sep 9, 2025 04:01PM Lucid Diagnostics Announces Proposed Public Offering of Common Stock
Apr 11, 2025 09:26AM Lucid Diagnostics (LUCD) Announces Closing of Public Offering of Common Stock
Apr 11, 2025 09:23AM Lucid Diagnostics Announces Closing of Public Offering of Common Stock
Apr 9, 2025 07:24PM Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
Apr 9, 2025 04:01PM Lucid Diagnostics (LUCD) Announces Proposed Public Offering of Common Stock
Apr 9, 2025 04:01PM Lucid Diagnostics Announces Proposed Public Offering of Common Stock
Jun 14, 2023 04:05PM PAVmed to Participate in Healthcare Virtual Conference Presented by Maxim Group LLC
Mar 10, 2021 09:30AM PAVmed to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
Feb 25, 2021 12:37PM PAVmed Announces Closing of its Public Offering of Common Stock
Feb 23, 2021 03:00PM PAVmed (PAVM) PT Raised to $8 at Maxim Group, Following Business Update
Feb 23, 2021 09:03AM PAVmed (PAVM) Prices 9.8M Share Common Offering for Gross Proceeds of Approx. $45M
Feb 23, 2021 09:00AM PAVmed Announces Pricing of $45 Million Public Offering of Common Stock
Jan 8, 2021 10:53AM PAVmed Closes $13.4 Million Common Stock Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Jan 6, 2021 09:30AM PAVmed (PAVM) Announces Registered Direct Offering of its Common Stock
Jan 6, 2021 09:29AM PAVmed Announces Registered Direct Offering of its Common Stock Priced At-the-Market under Nasdaq Rules
Dec 22, 2020 12:04PM PAVmed Closes Additional $8.1 Million Common Stock Registered Direct Offering
Dec 18, 2020 09:29AM PAVmed (PAVM) Prices Additional $8.1 Million Common Stock Registered Direct Offering
Dec 18, 2020 09:29AM PAVmed Announces Pricing of Additional $8.1 Million Common Stock Registered Direct Offering
Dec 11, 2020 09:29AM PAVmed (PAVM) Announces 5.6M Share Registered Direct Offering of its Common Stock Priced at $1.60/sh
Dec 11, 2020 09:29AM PAVmed Announces Registered Direct Offering of its Common Stock
Jul 13, 2020 09:30AM PAVmed to Present at Maxim Group’s COVID-19 Webinar on July 16, 2020
Mar 31, 2020 09:30AM PAVmed Receives $6.3 Million in Gross Proceeds from Completion of November 2019 Financing
Nov 5, 2019 07:00AM PAVmed Secures Financing up to $14 Million for Advancement of its Lead Products to Commercialization
Apr 12, 2019 09:35AM PAVmed (PAVM) Announces $1.6M Registered Direct Offering of its Common Stock
Apr 12, 2019 09:35AM PAVmed Announces Registered Direct Offering of its Common Stock
Jun 28, 2018 08:04AM UPDATE: Maxim Group Starts PAVmed (PAVM) at Buy
Jun 13, 2018 05:34PM Dawson James Securities Announces the Closing of Oversubscribed $10,350,000 Rights Offering for PAVmed, Inc.
Jun 13, 2018 05:34PM Dawson James Securities Announces the Closing of Oversubscribed $10,350,000 Rights Offering for PAVmed, Inc.
Jun 12, 2018 04:05PM PAVmed Closes Oversubscribed Rights Offering for Gross Proceeds of $10,350,000
Jun 8, 2018 07:30AM PAVmed to Receive $10.4 Million in Gross Proceeds from Oversubscribed Rights Offering
May 8, 2018 07:30AM PAVmed Sets Record Date for Previously Announced Rights Offering